Main research objectives for the group comprise:

Molinaro A, Braadland PR, Carpino G, Carreras A, Nikolaidis M, Hanzely P, Beck KR, Ali AH, Bossen L, Frank A, Lundqvist A, Juran BD, Overi D, Geng L, Amundsen-Isaksen E, Reims HM, Björk I, Grzyb K, Abildgaard A, Folseraas T, Cornillet M, Helgadóttir H, McCauley BM, Cristoferi L, Carbone M, Cardinale V, Høivik ML, Engesæter LK, Tjønnfjord SKV, McCann A et al. (2026)
Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling
Nat Metab (in press)
DOI 10.1038/s42255-026-01600-1, PubMed 42698000

Izquierdo-Sanchez L, Narbaiza J, Martin-Robles J, Lamarca A, Klümpen HJ, La Casta A, Valsan A, Roessler S, Braconi C, da Fonseca LG, Dopazo C, Juliebø AT, Mauro E, Buettner S, Balderramo D, Ponz-Sarvise M, Ferrer JD, Zieniewicz K, Utpatel K, Sparchez Z, Brustia R, Peck-Radosavljevic M, De Sario G, Gómez-Gavara C, Carrilho FJ, Tesini G, Nair P, Gutierrez E, Zonderhuis BM, Koerkamp BG et al. (2026)
Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry
J Hepatol (in press)
DOI 10.1016/j.jhep.2026.08.020, PubMed 42637053

Lapitz A, Grimsrud MM, Catanzaro E, Rodrigues PM, Hov JR, Azkargorta M, Val B, Vesterhus M, Grzyb K, Reims HM, Elortza F, Izquierdo-Sánchez L, Perugorria MJ, Bujanda L, Aabakken L, Paulsen V, Karlsen TH, Banales JM, Folseraas T (2026)
Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis
JHEP Rep, 102003 (in press)
DOI 10.1016/j.jhepr.2026.102003, PubMed 42628796